Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/HYPE3 stock hub

BVMF/HYPE3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/HYPE3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.4B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/HYPE3

In the news

Latest news · BVMF/HYPE3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.8

P25 11.3P50 14.6P75 19.6

Trailing P/E8.8

P25 15.2P50 21.5P75 27.3

ROE13

P25 5.3P50 12.3P75 22.5

ROIC12.1

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/HYPE3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

BRL

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	10,564
Employees Change	83%
Employees Change Percent	0.79
Enterprise value	BRL 22.7B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	BRHYPEACNOR0
Last refreshed	2026-05-10
Market cap	BRL 16.4B
Price	BRL 23.36
Price currency	BRL
Rev Per Employee	817,496.12x
Sector	Healthcare
Sic	2834
Symbol	bvmf/HYPE3
Website	https://www.hypera.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.24%
EV Earnings	13.51x
EV/EBIT	9.09x
EV/EBITDA	8.16x
EV/FCF	11.03x
EV/Sales	2.63x
FCF yield	12.54%
Forward P/E	7.83x
P/B ratio	1.16x
P/E ratio	8.84x
P/S ratio	1.9x
PE Ratio10 Y	18.36x
PE Ratio3 Y	13.66x
PE Ratio5 Y	14.6x
PEG ratio	0.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	28.68%
EBITDA Margin	31.16%
FCF margin	23.87%
Gross margin	60.74%
Gross Profit	BRL 5.2B
Gross Profit Growth	38.93%
Gross Profit Growth Q	137.24%
Gross Profit Growth3 Y	2.24%
Gross Profit Growth5 Y	13.07%
Net Income	BRL 1.7B
Net Income Growth	108.44%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	-0.1%
Net Income Growth5 Y	4.32%
Pretax Margin	18.5%
Profit Margin	19.49%
Profit Per Employee	BRL 159,348
Profitable Years	14
ROA	6.15
Roa5y	5.77
ROCE	10.98
ROE	12.95
Roe5y	13.89
ROIC	12.14
Roic5y	12.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.71%
Cagr15y	3.98%
Cagr1y	8.54%
Cagr3y	-10.4%
Cagr5y	-3.69%
Div CAGR10	40.01%
Div CAGR3	-2.51%
Div CAGR5	-0.81%
EPS Growth	108.5
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	0.09
EPS Growth5 Y	4.4
FCF Growth	-3.31%
FCF Growth Q	7.65%
FCF Growth3 Y	10.96%
FCF Growth5 Y	24.53%
OCF Growth	-3.99%
OCF Growth Q	-8.61%
OCF Growth10 Y	17.17%
OCF Growth3 Y	7.58%
OCF Growth5 Y	16.77%
Revenue Growth	28.96x
Revenue Growth Q	86.68x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	3.67x
Revenue Growth5 Y	14.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.34
Assets	BRL 26B
Cash	BRL 2.3B
Current Assets	BRL 6.7B
Current Liabilities	BRL 3.4B
Debt	BRL 8.6B
Debt EBITDA	BRL 3.12
Debt Equity	BRL 0.61
Debt FCF	BRL 4.18
Equity	BRL 14.1B
Interest Coverage	2.27
Liabilities	BRL 11.9B
Long Term Assets	BRL 19.3B
Long Term Liabilities	BRL 8.4B
Net Cash	BRL -6.3B
Net Cash By Market Cap	BRL -38.34
Net Debt EBITDA	BRL 2.34
Net Debt Equity	BRL 0.45
Net Debt FCF	BRL 3.06
Tangible Book Value	BRL 2B
Tangible Book Value Per Share	BRL 3.19
WACC	6.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.95
Inventory Turnover	1.61
Net Working Capital	BRL 1.7B
Quick ratio	1.29
Working Capital	BRL 3.3B
Working Capital Turnover	BRL 3.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.04%
Dividend Growth	6.46%
Dividend Growth Years	1%
Dividend per share	BRL 1.17
Dividend Years	11
Dividend Yield	5.01%
Ex Div Date	2026-04-01
Last Dividend	BRL 0.26
Payout Frequency	Quarterly
Payout Ratio	44.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	18.5%
1Y total return	8.54%
200-day SMA	23.71
3Y total return	-28.07%
50-day SMA	22.76
50-day SMA vs 200-day SMA	50under200
5Y total return	-17.12%
All Time High	51.11
All Time High Change	-54.29%
All Time High Date	2022-10-31
All Time Low	4.55
All Time Low Change	413.41%
All Time Low Date	2008-10-16
ATR	0.7
Beta	0.11
Beta1y	0.36
Beta2y	0.51
Ch YTD	-0.85
High	23.74
High52	28.87
High52 Date	2025-06-16
High52ch	-19.09%
Low	23.18
Low52	20.66
Low52 Date	2025-10-10
Low52ch	13.07%
Ma50ch	2.65%
Price vs 200-day SMA	-1.47%
RSI	54.5
RSI Monthly	44.69
RSI Weekly	49.88
Sharpe ratio	0.22x
Sortino ratio	0.47
Total Return	5.04%
Tr YTD	1.32
Tr15y	79.63%
Tr1m	0.65%
Tr1w	2.55%
Tr3m	0.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 2.5B
Operating Income Growth	166.5
Operating Income Growth3 Y	-0.45
Operating Income Growth5 Y	15.13
Operating margin	28.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	323,458,125%
Net Borrowing	-802,280,000
Shares Insiders	26.07%
Shares Institutions	31.24%
Shares Out	703,541,748
Shares Qo Q	-0.76%
Shares Yo Y	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 2B
Average Volume	3,904,500x
Bv Per Share	22.47
CAPEX	BRL -463.8M
Ch10y	-22.52
Ch15y	15.3
Ch1m	0.65
Ch1w	2.55
Ch1y	2.46
Ch3m	-1.23
Ch3y	-37.59
Ch5y	-32.72
Ch6m	-6
Change	0.43%
Change From Open	0.43
Close	23.26
Days Gap	0
Depreciation Amortization	213,924,000
Dollar Volume	147,859,456
Earnings Date	2026-04-28
EBIT	BRL 2.5B
EBITDA	BRL 2.7B
EPS	BRL 2.65
F Score	7
FCF	BRL 2.1B
FCF EV Yield	9.07x
FCF Per Share	BRL 2.93
Financing CF	-1,339,495,000
Fiscal Year End	December
Founded	1,999
Graham Number	36.58452
Graham Upside	56.61
Income Tax	BRL -77.9M
Investing CF	-615,069,000
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2010-01-04
Last Split Type	Forward
Lynch Fair Value	BRL 13.24
Lynch Upside	-43.34
Ma150	23.59
Ma150ch	-0.99%
Ma20	23.09
Ma20ch	1.16%
Net CF	570,792,000
Next Earnings Date	2026-08-06
Open	23.26
P FCF Ratio	7.97
P OCF Ratio	6.51
Position In Range	32.14
Ppne	4,300,662,000
Price Date	2026-05-08
Price EBITDA	BRL 6.11
Ptbv Ratio	8.21
Relative Volume	1.67x
Revenue	8,636,029,000x
SBC By Revenue	0.18x
Share Based Comp	15,477,000
Tax By Revenue	-0.9x
Tr6m	-2.72%
Volume	6,329,600

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/HYPE3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.0%

$1.17 annual per share

Payout ratio

+44.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-0.8%

1 consecutive years of growth

Total shareholder yield

+5.0%

Next ex-dividend date: 2026-04-01

Performance

BVMF/HYPE3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/HYPE3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.2%

Share of float held by funds and institutions

Insider ownership

+26.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

BVMF/HYPE3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.5

Neutral momentum band

Price vs 200-day MA

-1.5%

50/200-day relationship not available

Beta (5Y)

0.11

Less volatile than the market

Sharpe ratio

0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/HYPE3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/HYPE3 stock rating?

bvmf/HYPE3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/HYPE3 analysis?

The full report lives at /stocks/bvmf/HYPE3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/HYPE3?

The latest report frames bvmf/HYPE3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/HYPE3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.